DGAP-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: Management proposes full retention of 2019 net profits; virtual annual general meeting on 19 August 2020
DGAP-Ad-hoc: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Dividend/AGM/EGM
RHÖN-KLINIKUM Aktiengesellschaft: Management proposes full retention of 2019 net profits; virtual annual general meeting on 19 August 2020
09-Jul-2020 / 12:46 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Publication of insider information according to Article 17 EU Market Abuse Regulation (MAR)
RHÖN-KLINIKUM Aktiengesellschaft: Management proposes full retention of 2019 net profits; virtual annual general meeting on 19 August 2020
Bad Neustadt a. d. Saale, 9 July 2020. Today, the management board and supervisory board of RHÖN-KLINIKUM Aktiengesellschaft have unanimously approved an amendment of the proposal for the distribution of profits of the 2019 financial year. Following the ad hoc notice by RHÖN-KLINIKUM Aktiengesellschaft dated 16 May 2020 announcing that the initial proposal for a dividend payment of EUR 0.25 per dividend-bearing share would be reviewed because of the ongoing COVID-19 pandemic, management board and supervisory board now propose to fully retain the annual profit of EUR 203,529,952.42 because of the continuing uncertainties regarding the effects of the COVID-19 pandemic and the additional financial impact of the public takeover offer on profitability and liquidity of the company. The retention of the annual profit seeks to strengthen the capital and liquidity base and to maintain RHÖN-KLINIKUM Aktiengesellschaft's investment capability.
The annual general meeting 2020, at which a resolution on the proposal for the distribution of profits for the 2019 financial year is to be passed, will be held as a virtual general meeting on 19 August 2020.
Bad Neustadt a. d. Saale, 9 July 2020.
Your contact:
RHÖN-KLINIKUM AG |Head of Investor Relations and Treasury
Julian Schmitt
T. +49 9771 65-12250 | [email protected]
(notifying person)
RHÖN-KLINIKUM AG |Head of Corporate Communications and Marketing
Elke Pfeifer
T. +49 9771 65-12110 | [email protected]
09-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
|
Language: |
English |
Company: |
RHÖN-KLINIKUM Aktiengesellschaft |
|
Salzburger Leite 1 |
|
97616 Bad Neustadt a.d.Saale |
|
Germany |
Phone: |
+49 (0)9771 - 65-0 |
Fax: |
+49 (0)9771 - 97 467 |
E-mail: |
[email protected] |
Internet: |
www.rhoen-klinikum-ag.com |
ISIN: |
DE0007042301 |
WKN: |
704230 |
Indices: |
SDAX |
Listed: |
Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange |
EQS News ID: |
1090073 |
|
End of Announcement |
DGAP News Service |
1090073 09-Jul-2020 CET/CEST
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
Umsatzerlöse1 |
1.211,08 |
1.232,91 |
1.303,90 |
1.360,16 |
1.402,01 |
1.446,09 |
1.463,98 |
EBITDA1,2 |
97,82 |
125,54 |
125,33 |
80,23 |
101,16 |
105,65 |
105,88 |
EBITDA-Marge3 |
8,08 |
10,18 |
9,61 |
5,90 |
7,22 |
7,31 |
|
EBIT1,4 |
38,70 |
64,94 |
56,80 |
10,60 |
30,52 |
36,11 |
40,40 |
EBIT-Marge5 |
3,20 |
5,27 |
4,36 |
0,78 |
2,18 |
2,50 |
2,76 |
Jahresüberschuss1 |
36,74 |
51,19 |
44,48 |
2,46 |
30,23 |
26,94 |
40,17 |
Netto-Marge6 |
3,03 |
4,15 |
3,41 |
0,18 |
2,16 |
1,86 |
2,74 |
Cashflow1,7 |
80,30 |
49,50 |
47,30 |
113,30 |
97,50 |
41,30 |
109,00 |
Ergebnis je Aktie8 |
0,53 |
0,73 |
0,65 |
0,02 |
0,42 |
0,38 |
0,58 |
Dividende8 |
0,22 |
0,29 |
0,00 |
0,00 |
0,00 |
0,15 |
0,35 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen.
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: KPMG
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Rhön-Klinikum |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
704230 |
10,900 |
Halten |
729,89 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
18,17 |
28,00 |
0,64 |
18,63 |
KBV |
KCV |
KUV |
EV/EBITDA |
0,58 |
6,70 |
0,50 |
6,30 |
Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e in % |
Hauptversammlung |
0,15 |
0,00 |
0,00 |
05.06.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
08.05.2024 |
08.08.2024 |
07.11.2024 |
28.03.2024 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
0,87% |
-2,85% |
9,00% |
-16,15% |
|
|